Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
EF-001 by Everfront Biotech for Glioblastoma Multiforme (GBM): Likelihood of Approval
EF-001 is under clinical development by Everfront Biotech and currently in Phase II for Glioblastoma Multiforme (GBM). According to GlobalData,...
EF-001 by Everfront Biotech for Anaplastic Astrocytoma: Likelihood of Approval
EF-001 is under clinical development by Everfront Biotech and currently in Phase II for Anaplastic Astrocytoma. According to GlobalData, Phase...
EF-001 by Everfront Biotech for High-Grade Glioma: Likelihood of Approval
EF-001 is under clinical development by Everfront Biotech and currently in Phase II for High-Grade Glioma. According to GlobalData, Phase...